SummitTX Capital »

Design Therapeutics shares owned by SummitTX Capital

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by SummitTX Capital from 13F filings

Historical chart of SummitTX Capital investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by SummitTX Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by SummitTX Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.2M 81k 14.47

More positions owned by SummitTX Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Analog Devices (ADI)
MKS Instruments (MKSI)
Asml Hldg Nv N Y Registry Shs (ASML)
Warner Bros Discovery Com Ser A (WBD)
Applied Materials (AMAT)
Select Sector Spdr Tr St Str Indl Etf (XLI)
Nxp Semiconductors N V (NXPI)
Amazon (AMZN)
O'reilly Automotive (ORLY)
Cbre Group Cl A (CBRE)
Electronic Arts (EA)
Micron Technology (MU)
3M Company (MMM)

View all positions for SummitTX Capital

Top funds holding Design Therapeutics

Sr One Capital Management
Logos Global Management
Baker Bros. Advisors
Driehaus Capital Management
BlackRock
Caption Management
Point72 Asset Management
Trails Edge Capital Partners
Frazier Life Sciences Management
Vivo Capital
Vanguard Capital Management
Almitas Capital
Geode Capital Management
Sofinnova Ventures
FMR

View all funds holding Design Therapeutics